Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYBB | P04839 | 4/20 | 0.42 |
| ▸ | NOX4 | Q9NPH5 | 4/20 | 0.42 |
| ▸ | MTNR1A | P48039 | 2/20 | 0.39 |
| ▸ | MTNR1B | P49286 | 2/20 | 0.39 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | NTSR1 | P30989 | 10/20 | 0.35 |
| ▸ | PLK1 | P53350 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29752123 | 0.87 | ALDH1A1 (0.43) | L3MBTL1ALDH1A1 | |
| SCHEMBL179136 | 0.87 | ALDH1A1 (0.43) | L3MBTL1ALDH1A1 | |
| SCHEMBL24855527 | 0.85 | ALDH1A1 (0.36) | CYBBNOX4MTNR1AMTNR1BL3MBTL1 | |
| Hydrochloric Acid SCHEMBL564874 | 0.85 | ALDH1A1 (0.42) | L3MBTL1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL29361270 | 0.85 | ALDH1A1 (0.42) | L3MBTL1ALDH1A1 | |
| SCHEMBL11309184 | 0.79 | ALDH1A1 (0.44) | L3MBTL1ALDH1A1 | |
| SCHEMBL16003519 | 0.78 | CYBB (0.42) | CYBBNOX4MTNR1AMTNR1BALDH1A1 | |
| Hydrochloric Acid SCHEMBL11287024 | 0.78 | ALDH1A1 (0.42) | L3MBTL1ALDH1A1 | |
| Hydrochloric Acid SCHEMBL9015911 | 0.78 | L3MBTL1 (0.37) | CYBBNOX4L3MBTL1ALDH1A1 | |
| SCHEMBL3720237 | 0.77 | ALDH1A1 (0.47) | CYBBNOX4MTNR1AMTNR1BALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9594052-B2 | Methods of failsafing electrochemical measurements of an analyte as well as devices, apparatuses and systems incorporating the same | ROCHE DIABETES CARE, INC. (US) | 2017-03-14 | — | — | US | disclosed |
| US-8008037-B2 | Matrix composition with alkylphenazine quaternary salt and a nitrosoaniline | ROCHE DIAGNOSTICS OPERATIONS, INC. (US) | 2011-08-30 | — | — | US | disclosed |